Navigation Links
Drug Trial Proves Nightmare for British Indian Student

An Indian student who completed a management course here and agreed to be part of a drug trial has been struggling to cope with the effects of the trial and is looking// forward to returning to India.

Navneet Modi, the student, agreed to a drug trial for US testing firm Parexel in March, but is now said to be a pale shadow of his former outgoing self. He is reported to be taking antidepressants and medication to stop his skin itching.

London-based Modi also has problems with his bowels and kidneys and his eyes feel permanently dry. He needs to apply eye drops regularly. Reports say that he may have suffered long-term damage, including malignant lymphoma, which the drug was supposed to cure.

He told the Evening Standard: 'I have memory problems. I can't remember my family. I keep crying for no reason. I feel so unsure about the future.'

Parexel had reportedly paid him almost 4,000 pounds for trials on two previous occasions.

'Parexel has done nothing for us. Parexel has refused to get involved. They wouldn't even pay for the taxi to take us home from hospital,' he said.

Reports say that on the day of the trial, he was the third of the guinea pigs to be injected with TGN1412. It was 8.30 a.m. and he started suffering headaches but was told not to worry. By 9.15 a.m., he felt pressure in his skull and in his back. He says he was given paracetamol for the pain.

By 10.00 a.m. he was slipping in and out of consciousness. Around midnight he was wheeled into Northwick Park's intensive care unit where he was given steroids that his lawyers argue should have been administered almost 16 hours earlier.

(Source: IANS)
'"/>




Page: 1

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Vaccine For Dengue Fever On Trial In Asia-Pacific
3. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
4. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
5. Sex, Race Influence Lung Cancer Trial Participation
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
8. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
9. China Begins Human Trials For HIV/AIDS Drug
10. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
11. HIV/AIDS Vaccine Trial To Be Initiated Soon
Post Your Comments:
(Date:8/29/2008)...nowitzmd.com [Los Angeles cosmetic surgeon], Dr. ...c surgery procedures for post bariatric weight los...y for these patients, health and wellness. Dr. Ar... procedures for after weight loss. , ...8 -- Bariatric surgery improves the health of morb...
(Date:8/28/2008)...swire/ -- The 2008 European,Hemodialysis Emerging ...,Medical in recognition of its pioneering Redsense...e detects the loss of blood during hemodialysis,an...ce consists of an alarm and a sensor patch. The se...echnology that sends signals,alerting caregivers a...
(Date:8/28/2008)...t patients and doctors say drug is hard to manage ...- Only 40 percent of patients with atrial fibrilla...er a stroke were taking the anti-clotting drug war...warfarin, 75 percent weren,t getting the dose need...nt were taking medications that were less effectiv...
(Date:8/28/2008)...en low levels of the metal can double risk , ... metal cadmium plays a major role in causing emphy...nd smoke and other sources can increase the risk o...sity of Michigan School of Public Health research ...ium in their bodies may have as much as double the...
Breaking Medicine News(10 mins):Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Cadmium Exposure Tied to Lung Disease 2
...al, Inc. today announced the first patient implant... if stimulating nerves near the spinal cord will c...3-year-old Massachusetts woman is the first person...e, called the Genesis? Neurostimulation System. Sh...
...time, experimental results indicate that it is pos...n proteins from the blood of an infected animal, /...oval of infectious prion proteins – the agents ass...ad cow disease, scrapie and other prion diseases i...
...oes get their rich color from lycopene, a disease-...ts that a special variety of orange-colored tomato...t our bodies may more readily use. Researchers fou...uce made from these orange tomatoes, called Tanger...
... incidence of malaria, one of the most common vect...2 million cases in 2005 to 1.2 million cases in 20... of the social sectors, the Economic Survey said m... from 963 to 961 people in the country in this per...
Other Medicine News:Health News:Spinal Cord Stimulation Pilot Study for Chronic Angina 2Health News:Researchers Develop Resin Beads That Capture Mad Cow Disease Agent From Blood 2Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 2Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 3Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2
(Date:8/26/2008)...- The Oregon Tourism Commission,launched its new f...Program,(Q Care) this week on http://www.OregonQC...eated to support the tourism and,hospitality indus...izing,the importance of quality customer service, ...esources to better serve Oregon,s visitors., "We,...
(Date:8/26/2008)...-- Semafore Pharmaceuticals Inc.,announced data pr...argeted,Therapies in Cancer in Washington, D.C., s...lar-targeted PI3 kinase (PI3K) inhibitor SF1126, b...part of a very powerful pathway, the PI3/AKT /mTOR...in cancer. Studies have shown that by,inhibiting t...
(Date:8/26/2008)... safely six weeks following surgical,treatment, R...Six weeks following,bunion surgery, most patients,...back behind the wheel of a car again. A study publ...one and Joint Surgery ( http://www.jbjs.org/ ),als...ents who underwent a,first metatarsal osteotomy (a...
(Date:8/26/2008)... -- Cambridge Research &,Instrumentation, Inc. (CR...Vivo Imaging System. The new system incorporates C...the entry-level instrument of choice for in,vivo f....com/cgi-bin/prnh/20080826/NETU054 ), FLEX techn...s unique,solid-state tunable optics that for the f...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Braking After Bunion Surgery 2Braking After Bunion Surgery 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 1Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 2Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 3INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 1INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 2INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 3INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 4INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 5INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 6Network Health Awards Contract to HMS for Coordination of Benefits 8105 1Network Health Awards Contract to HMS for Coordination of Benefits 8105 2Kaiser Permanente to Host 30th Annual Diversity Conference 2152 1Kaiser Permanente to Host 30th Annual Diversity Conference 2152 2Kaiser Permanente to Host 30th Annual Diversity Conference 2152 3
... Safety and Single-Agent Activity Support Developm...Glioblastoma Multiforme, ROCKVILLE, Md., June 05, ...clinical-stage pharmaceutical company developing,t...matory diseases,announces the presentation of res... NCD (2ME2) in patients with glioblastoma,multifor...
... FLEMINGTON, N.J.--(BUSINESS WIRE)--Jun 5, 2007 - ...aceutical company developing,oral spray formulatio... announced that its two clinical studies comparing...t their primary,pharmacokinetic (PK), pharmacodyna...re currently marketed as Ambien(R), a leading,drug...
Other Medicine Technology:Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
...xtend is a three-part differential control assayed... J Series, T Series, AcT/AcT diff/AcT diff2, MD Se...1600, 1700, and 1800; ABX Micros 60; and Diatron A...n-vial stability of 30 days and a six-month closed...
From top to bottom, EZ STEER Bi-Directional Catheters put amazing responsiveness, predictability, and comfort close at hand. Utilizing a patented Biosense Webster micro-tensioning system that enables
... Auto is a whole blood control for evaluating the ...hat measure automated blood cell counts in patient...and WBC values for the Abbott CELL-DYN 3200, 4000 ... 2 and 3 only) and Sysmex XE-2100 instruments. Cel...
..., a whole blood assayed hematology control, offers...l differential available with the Coulter GENS, ST...pen-vial stability, 105-day closed-vial stability ...he 4.0ml pierceable cap vial is compatible with al...
Medicine Products: